Amyotrophic lateral sclerosis patients show executive impairments on standard neuropsychological measures and an ecologically valid motor-free test of executive functions

Journal of Clinical and Experimental Neuropsychology

Volumn 32, Issue 10, 2010, Pages 1095-1109

  Štukovnik, Vita ^a   Zidar, Janez ^a   Podnar, Simon ^a   Repovš, Grega ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Amyotrophic lateral sclerosis; Ecological validity; Executive dysfunction; Medication Scheduling Task; Motor free assessment of executive functions

Indexed keywords

NEUROPROTECTIVE AGENT; RILUZOLE;

ALGORITHM; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BACK; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; SELF MEDICATION; SPINE DISEASE; STROOP TEST; VERBAL BEHAVIOR;

ALGORITHMS; AMYOTROPHIC LATERAL SCLEROSIS; BACK; COGNITION DISORDERS; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; RILUZOLE; SELF MEDICATION; SPINAL DISEASES; STROOP TEST; VERBAL BEHAVIOR;

EID: 78650095653     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803391003749236     Document Type: Article

References (89)

1. Abe, K., Fujimura, H., Toyooka, K., Sakoda, S., Yorifuji, S., & Yanagihara, T. (1997). Cognitive function in amyotrophic lateral sclerosis. Journal of Neurological Sciences, 148(1), 95-100.
2. Abrahams, S., Goldstein, L. H., Al-Chalabi, A., Pickering, A., Morris, R. G., Passingham, R. E., et al. (1997). Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, & Psychiatry, 62(5), 464-472.
3. Abrahams, S., Goldstein, L. H., Kew, J. J., Brooks, D. J., Lloyd, C. M., Frith, C. D., et al. (1996). Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain, 119(6), 2105-2120.
4. Abrahams, S., Goldstein, L. H., Simmons, A., Brammer, M., Williams, S. C., Giampietro, V., et al. (2004). Word retrieval in amyotrophic lateral sclerosis: A functional magnetic resonance imaging study. Brain, 127(7), 1507-1517.
5. Abrahams, S., Leigh, P. N., & Goldstein, L. H. (2005). Cognitive change in ALS: A prospective study. Neurology, 64(7), 1222-1226.
6. Abrahams, S., Leigh, P. N., Harvey, A., Vythelingum, G. N., Grisé, D., & Goldstein, L. H. (2000). Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia, 38(6), 734-747.
7. Alderman, N., Burgess, P. W., Knight, C., & Henman, C. (2003). Ecological validity of a simplified version of the multiple errands shopping test. Journal of the International Neuropsychological Society, 9(1), 31-44.
8. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
9. Bak, T. H., & Hodges, J. R. (2004). The effects of motor neuron disease on language: Further evidence. Brain and Language, 89(2), 354-361.
10. Battig, W. F., & Montague, W. E. (1969). Category norms for verbal items in 56 categories: A replication and extension of the Connecticut category norms. Journal of Experimental Psychology Monographs, 80(3), 1-46.
11. Benton, A. L., Sivan, A. B., Hamsher, K. deS., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment. A clinical manual (2nd ed.). New York: Oxford University Press.
12. Birn, R. M., Kenworthy, L., Case, L., Caravella, R., Jones, T. B., Bandettini, P. A., et al. (2010). Neural systems supporting lexical search guided by letter and semantic category cues: A self-paced overt response fMRI study of verbal fluency. NeuroImage, 49(1), 1099-1107.
13. Brooks, B. R., Miller, R. G., Swash, M., Munsat, T. L., & World Federation of Neurology Research Group on Motor Neuron Diseases. (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 15, 293-299.
14. Brosnan-Watters, G., Wozniak, D. F., Nardi, A., & Olney, J. W. (1996). Acute behavioral effects of MK-801 in the mouse. Pharmacology, Biochemistry and Behavior, 53(3), 701-711.
15. Brownell, B., Oppenheimer, D. R., & Hughes, J. T. (1970). The central nervous system in motor neurone disease. Journal of Neurology, Neurosurgery, & Psychiatry, 33(3), 338-357.
16. Burgess, P. W. (2000). Strategy application disorder: The role of the frontal lobes in human multitasking. Psychological Research, 63 (3-4), 279-288.
17. Burgess, P. W., Alderman, N., Evans, J., Emslie, H., & Wilson, B. A. (1998). The ecological validity of tests of executive function. Journal of the International Neuropsychological Society, 4(6), 547-558.
18. Burgess, P. W., Alderman, N., Forbes, C., Costello, A., Coates, L. M., Dawson, D. R., et al. (2006). The case for the development and use of "ecologically valid" measures of executive function in experimental and clinical neuropsychology. Journal of the International Neuropsychological Society, 12(2), 194-209.
19. Burgess, P. W., & Shallice, T. (1996). Response suppression, initiation and strategy use following frontal lobe lesion. Neuropsychologia, 34, 263-276.
20. Carlson, M. C., Fried, L. P., Xue, Q. L., Tekwe, C., & Brandt, J. (2005). Validation of the Hopkins Medication Schedule to identify difficulties in taking medications. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60(2), 217-223.
21. Cedarbaum, J. M., & Stambler, N. (1997). Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. Journal of Neurological Sciences, 152 (Suppl. 1), S1-S9.
22. Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychological Review, 13(4), 181-197.
23. Chaytor, N., Schmitter-Edgecombe, M., & Burr, R. (2006). Improving the ecological validity of executive functioning assessment. Archives of Clinical Neuropsychology, 21(3), 217-227.
24. Cobble, M. (1998). Language impairment in motor neurone disease. Journal of Neurological Sciences, 160 (Suppl. 1), S47-S52.
25. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
26. Cohen, J. (1992). "A power primer." Psychological Bulletin, 112, 155-159.
27. Corrigan, J. D., & Hinkeldey, N. S. (1987). Relationships between Parts A and B of the Trail Making Test. Journal of Clinical Psychology, 43(4), 402-409.
28. Cripe, L. I. (1996). The ecological validity of executive function testing. In R. J. Sordone & C. J. Long (Ed.), Ecological validity of neuropsychological testing (pp. 171-202). Delray Beach, FL: Gr. Press/St. Lucie Press.
29. Culbertson, C. W., & Zillmer, E. A. (2001). Tower of London (TOLDX). Toronto, Canada: Multi Health Systems.
30. Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). Delis-Kaplan Executive Function System battery. San Antonio, TX: Harcourt Assessment Company.
31. Duncan, J., Burgess, P., & Emslie, H. (1995). Fluid intelligence after frontal lobe lesions. Neuropsychologia, 33(3), 261-268.
32. Eisen, A., & Krieger, C. (1993). Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis. Canadian Journal of Neurological Sciences, 20(4), 286-296. (Pubitemid 24013590)
33. Eslinger, P. J., & Damasio, A. R. (1985). Severe disturbance of higher cognition after bilateral frontal lobe ablation: Patient EVR. Neurology, 35(12), 1731-1741.
34. Evans, J. J., Chua, S. E., McKenna, P. J., & Wilson, B. A. (1997). Assessment of the dysexecutive syndrome in schizophrenia. Psychological Medicine, 273, 635-646.
35. Ferguson, K. A., Strong, M. J., Ahmad, D., & George, C. F. (1996). Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest, 110, 664-669.
36. Frank, B., Haas, J., Heinze, H. J., Stark, E., & Münte, T. F. (1997). Relation of neuropsychological and magnetic resonance findings in amyotrophic lateral sclerosis: Evidence for subgroups. Clinical Neurology and Neurosurgery, 99(2), 79-86.
37. Gibbons, Z. C., Snowden, J. S., Thompson, J. C., Happé, F., Richardson, A., & Neary, D. (2007). Inferring thought and action in motor neuron disease. Neuropsychologia, 45(6), 1196-1207.
38. Goldstein, G., & McCue, M. (1995). Differences between patient and informant functional outcome ratings in headinjured individuals. International Journal of Rehabilitation and Health, 1, 25-35.
39. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62.
40. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
41. Hartikainen, P., Helkala, E. L., Soininen, H., & Riekkinen, P., Sr. (1993). Cognitive and memory deficits in untreated Parkinson's disease and amyotrophic lateral sclerosis patients: A comparative study. Journal of Neural Transmission, Parkinson's Disease and Dementia Section, 6(2), 127-137.
42. Hudson, A. J. (1981). Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: A review. Brain, 104(2), 217-247.
43. Jurica, P. J., Leitten, C. L., & Mattis, S. (2001). Dementia rating scale-2. Odessa, FL: Psychological Assessment Resources.
44. Kaitaro, T., Koskinen, S., & Kaipio, M. L. (1995). Neuropsychological problems in everyday life: A 5-year follow-up study of young severely closed-head-injured patients. Brain Injury, 97, 713-727.
45. Kaufman, A. S., Kaufman, J. C., Liu, X., & Johnson, C. K. (2009). How do educational attainment and gender relate to fluid intelligence, crystallized intelligence, and academic skills at ages 22-90 years? Archives of Clinical Neuropsychology, 24(2), 153-163.
46. Kew, J. J., Goldstein, L. H., Leigh, P. N., Abrahams, S., Cosgrave, N., Passingham, R. E., et al. (1993a). The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain, 116(6), 1399-1423.
47. Kew, J. J., Leigh, P. N., Playford, E. D., Passingham, R. E., Goldstein, L. H., Frackowiak, R. S., et al. (1993b). Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain, 116(3), 655-680.
48. Kiernan, J. A., & Hudson, A. J. (1994). Frontal lobe atrophy in motor neuron diseases. Brain, 117, 747-757.
49. Kilani, M., Micallef, J., Soubrouillard, C., Rey-Lardiller, D., Dematteï, C., Dib, M., et al. (2004). A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5(1), 46-54.
50. Leigh, P. N., & Ray-Chaudhuri, K. (1994). Motor neuron disease. Journal of Neurology, Neurosurgery, & Psychiatry, 57(8), 886-896.
51. Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). Oxford, UK: Oxford University Press.
52. Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J. H., Olney, R. K., & Miller, B. (2003). Are amyotrophic lateral sclerosis patients cognitively normal? Neurology, 60(7), 1094-1097.
53. Ludolph, A. C., Langen, K. J., Regard, M., Herzog, H., Kemper, B., Kuwert, T., et al. (1992). Frontal lobe function in amyotrophic lateral sclerosis: A neuropsychologic and positron emission tomography study. Acta Neurologica Scandinavica, 85(2), 81-89.
54. Maekawa, S., Al-Sarraj, S., Kibble, M., Landau, S., Parnavelas, J., Cotter, D., et al. (2004). Cortical selective vulnerability in motor neuron disease: A morphometric study. Brain, 127(6), 1237-1251.
55. Manchester, D., Priestley, N., & Jackson, H. (2004). The assessment of executive functions: Coming out of the office. Brain Injury, 18(11), 1067-1081.
56. Mantovan, M. C., Baggio, L., Dalla Barba, G., Smith, P., Pegoraro, E., Soraru, G., et al. (2003). Memory deficits and retrieval processes in ALS. European Journal of Neurology, 10(3), 221-227.
57. Massman, P. J., Sims, J., Cooke, N., Haverkamp, L. J., Appel, V., & Appel, S. H. (1996). Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, & Psychiatry, 61(5), 450-455.
58. Mendez, C. V., Hurley, R. A., Lassonde, M., Zhang, L., & Taber, K. H. (2005). Mild traumatic brain injury: Neuroimaging of sports-related concussion. Journal of Neuropsychiatry and Clinical Neuroscience, 17(3), 297-303.
59. Mitsuyama, Y. (1984). Presenile dementia with motor neuron disease in Japan: Clinico-pathological review of 26 cases. Journal of Neurology, Neurosurgery, & Psychiatry, 47(9), 953-959.
60. Miyake, A., Emerson, M. J., & Friedman, N. P. (2000). Assessment of executive functions in clinical settings: Problems and recommendations. Seminars in Speech and Language, 21(2), 169-183.
61. Moretti, R., Torre, P., Antonello, R. M., Carraro, N., Cazzato, G., & Bava, A. (2002). Complex cognitive disruption in motor neuron disease. Dementia and Geriatric Cognitive Disorders, 14(3), 141-150.
62. Norris, F. H., Jr., Calanchini, P. R., Fallat, R. J., Panchari, S., & Jewett, B. (1974). The administration of guanidine in amyotrophic lateral sclerosis. Neurology, 24, 721-728.
63. Ogawa, T., Tanaka, H., & Hirata, K. (2009). Cognitive deficits in amyotrophic lateral sclerosis evaluated by event-related potentials. Clinical Neurophysiology, 120(4), 659-664.
64. Olney, R. K., Murphey, J., Forshew, D., Garwood, E., Miller, B. L., Langmore, S., et al. (2005). The effects of executive and behavioral dysfunction on the course of ALS. Neurology, 65(11), 1774-1777.
65. Oye, I., Paulsen, O., & Maurset, A. (1992). Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors. Journal of Pharmacology and Experimental Therapeutics, 260(3), 1209-1213.
66. Phukan, J., & Hardiman, O. (2009). The management of amyotrophic lateral sclerosis. Journal of Neurology, 256(2), 176-186.
67. Phukan, J., Pender, N. P., & Hardiman, O. (2007). Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurology, 6(11), 994-1003. (Pubitemid 47562321)
68. Portet, F., Cadilhac, C., Touchon, J., & Camu, W. (2001). Cognitive impairment in motor neuron disease with bulbar onset. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2(1), 23-29.
69. Raaphorst, J., De Visser, M., Linssen, W. H., De Haan, R. J., & Schmand, B. (2009). The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis. Amyotrophic Lateral Sclerosis, 29, 1-13.
70. Rabkin, J. G., Wagner, G. J., & Del Bene, M. (2000). Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosomatic Medicine, 62(2), 271-279.
71. Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271-276.
72. RepovŠ, G., Foster, E., & Hershey, T. (2010). Medication Scheduling Task-an ecologically relevant executive function task differentially sensitive to neurological disorders. Manuscript in preparation.
73. Reynolds, C. R. (2002). Comprehensive Trail-Making Test. San Antonio, TX: Pro-ed.
74. Reynolds, M., & Kobak, K. A. (1995). Hamilton depression inventory: A self-report version of the Hamilton depression rating scale (HDRS). Odessa, FL: Psychological Assessment Resources.
75. Ringholz, G. M., Appel, S. H., Bradshaw, M., Cooke, N. A., Mosnik, D. M., & Schulz, P. E. (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology, 65(4), 586-590.
76. Rippon, G. A., Scarmeas, N., Gordon, P. H., Murphy, P. L., Albert, S. M., Mitsumoto, H., et al. (2006). An observational study of cognitive impairment in amyotrophic lateral sclerosis. Archives of Neurology, 63(3), 345-352.
77. Röttig, D., Leplow, B., Eger, K., Ludolph, A. C., Graf, M., & Zierz, S. (2006). Only subtle cognitive deficits in non-bulbar amyotrophic lateral sclerosis patients. Journal of Neurology, 253(3), 333-339.
78. Saletu, B., Grünberger, J., Anderer, P., & Linzmayer, L. (1996). Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Methods & Findings in Experimental & Clinical Pharmacology, 18(1), 55-66. (Pubitemid 26100331)
79. Schillerstrom, J. E., Horton, M. S., & Royall, D. R. (2005). The impact of medical illness on executive function. Psychosomatics, 46(6), 508-516.
80. Schreiber, H., Gaigalat, T., Wiedemuth-Catrinescu, U., Graf, M., Uttner, I., Muche, R., et al. (2005). Cognitive function in bulbar-and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. Journal of Neurology, 252(7), 772-781.
81. Shallice, T., & Burgess, P. W. (1991). Deficits in strategy application following frontal lobe damage in man. Brain, 114(2), 727-741.
82. Strong, M. J., Grace, G. M., Freedman, M., Lomen-Hoerth, C., Woolley, S., Goldstein, L. H., et al. (2009). Consensus criteria for the diagnosis of frontotemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 10(3), 131-146.
83. Strong, M. J., Grace, G. M., Orange, J. B., & Leeper, H. A. (1996). Cognition, language, and speech in amyotrophic lateral sclerosis: A review. Journal of Clinical and Experimental Neuropsychology, 18(2), 291-303.
84. Strong, M. J., Grace, G. M., Orange, J. B., Leeper, H. A., Menon, R. S., & Aere, C. (1999). A prospective study of cognitive impairment in ALS. Neurology, 53(8), 1665-1670.
85. Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643-662.
86. Sunderland, A., Harris, J. E., & Baddeley, A. D. (1983). Do laboratory tests predict everyday memory? A neuropsychological study. Journal of Verbal Learning and Verbal Behaviour, 22, 341-357.
87. Talbot, P. R., Goulding, P. J., Lloyd, J. J., Snowden, J. S., Neary, D., & Testa, H. (1995). Inter-relation between "classic" motor neuron disease and frontotemporal dementia: Neuropsychological and single photon emission computed tomography study. Journal of Neurology, Neurosurgery, & Psychiatry, 58(5), 541-547.
88. Wilson, B. A., Alderman, N., Burgess, P. W., Emslie, H., & Evans, J. J. (1996). Behavioural assessment of the dysexecutive syndrome. Bury St. Edmunds, UK: Thames Valley Test Company.
89. Wozniak, D. F., Olney, J. W., Kettinger, L., III, Price, M., & Miller, J. P. (1990). Behavioral effects of MK-801 in the rat. Psychopharmacology (Berlin), 101(1), 47-56.